Boehringer Ingelheim Pharmaceuticals
UEI: S5ARNQCRHMZ7
• DBA: BOEHRINGER INGELHEIM VETMEDICA INC
Overview
Awardee Type
Parent
(2 children)
Name
Boehringer Ingelheim Pharmaceuticals
Headquarters
Duluth, GA
United States
United States
Most Recent Award
March 11, 2025
Calculating
Federal contract and grant recipient
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC
dba BOEHRINGER INGELHEIM VETMEDICA INC
(UEI S5ARNQCRHMZ7)
is headquartered in Duluth GA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 1917 and
federally registered in
April 2002.
Federal Award Analysis
Boehringer Ingelheim Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI N8ZHMK52HNG9 CAGE 50614 instead.
Legal Name
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC
DBA
BOEHRINGER INGELHEIM VETMEDICA INC
UEI
N8ZHMK52HNG9
CAGE Code
50614
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 1, 1917
Initial Registration
April 18, 2002
Last Registration
Feb. 7, 2025
Registration Activation
Feb. 7, 2025
Registration Expiration
Feb. 5, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Boehringer Ingelheim Pharmaceuticals
GSA Schedules and Price Lists
- Boehringer Ingelheim Pharmaceuticals
- PoP: 9/14/22 - 9/14/27
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Boehringer Ingelheim Pharmaceuticals
- PoP: 3/31/15 - 9/14/22 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $4,320